P2.09-33 A Phase II Trial of Anlotinib Plus Osimertinib in Advanced NSCLC with EGFR T790M Mutation After Failure of Prior EGFR TKIs.

Details

Language :

English

ISSN :

15560864

Volume :

18

Issue :

11

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

173323200

Full Text :

https://doi.org/10.1016/j.jtho.2023.09.606